Abstract

Summary

Rett Syndrome mouse models lacking MeCP2 exhibit profound disruption of circadian rhythms including fragmented sleep, weakened SCN clockwork, and disorganized peripheral oscillators, suggesting that stabilizing circadian rhythms should be a clinical priority for RTT patients. For lighting and healthcare professionals, these findings imply that structured light-dark cycle interventions may be particularly important in managing sleep and circadian dysfunction in RTT individuals.
Abstract

Key Findings

  • Mecp2-/y mice showed severely fragmented sleep behavior and deficits in circadian locomotor activity rhythms compared to wild-type controls
  • Spontaneous electrical activity in the SCN was significantly attenuated in Mecp2-/y mice, indicating weakened central clockwork
  • Core clock gene expression was disrupted in both SCN and peripheral organs of Mecp2-/y mice
  • ChIP-qPCR revealed loss of rhythmic histone marker binding at clock gene promoters in Mecp2-/y mouse embryonic fibroblasts
  • RTT patient-derived fibroblasts exhibited abnormal core clock gene expression, confirming translational relevance
  • Mecp2-/y mice had shortened lifespan attributed in part to destabilized circadian system
  • 7,8-DHF (TrkB agonist) did not significantly rescue lifespan in vivo but increased spontaneous firing rate of L5 pyramidal neurons in vitro
Categories

Categories

Sleep & Circadian Health: Mecp2-/y mice show severe circadian locomotor rhythm deficits, fragmented sleep, and attenuated SCN electrical activity and clock gene expression, revealing MeCP2's essential role in the circadian timing system.
The Science of Light: The study examines SCN molecular clockwork and peripheral oscillator disruption at a mechanistic level, including histone marker rhythmicity at clock gene promoters, relevant to understanding circadian system biology.
Authors

Author(s)

Q Li
Publication Date

Publication Year

2014
View more publications